NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its portfolio of proprietary genetic biomarkers, announced today that its PGxHeatlh™ division will feature two presentations at the Heart Rhythm Society’s Heart Rhythm 2008 conference. The presentations are on Long QT Syndrome, an inherited cardiac condition for which the company offers a proprietary test.
